Funds and ETFs Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Equities

300318

CNE000001QR4

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-04-29 EDT 5-day change 1st Jan Change
5.21 CNY +0.77% Intraday chart for Beijing Bohui Innovation Biotechnology Group Co., Ltd. +9.00% -16.51%

ETFs positioned on Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +2.67% -
Beijing Bohui Innovation Biotechnology Group Co Ltd, formerly Beijing Bohui Innovation Biotechnology Co Ltd, is a China-based company mainly engaged in inspection and testing business and blood products business. The Company operates two major reporting segments. The Inspection and Testing segment is mainly engaged in the research and development, production and sales of inspection instruments and inspection reagents. The Company's products for medical institutions mainly involve in vitro diagnostic testing, including human trace element testing and human papillomavirus (HPV) testing. The Company's testing equipment for non-medical institutions is mainly small mass spectrometers and related products. The Biological Products segment is mainly blood products, which can be divided into products such as albumin, immunoglobulin, coagulation factors and vaccines. The Company distributes its products within the domestic market and to overseas market.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300318 Stock
  4. Funds and ETFs Beijing Bohui Innovation Biotechnology Group Co., Ltd.